International Business TimesNanoparticles reprogram immune cells to fight cancerScience DailyThe study provides proof-of-principle that the nanoparticles can educate the immune system to target cancer cells. Stephan and his team designed the new CAR ge… Continue reading
WDTN |
Ryan Custer may join stem cell study
WDTN Custer’s Recovery Care page says Ryan has been approved to participate in a stem cell study at Rush University in Chicago. This, after he shattered his c5 vertebrae jumping into a makeshift pool at a party in Oxford. The study would use human embryonic … |
Futurism |
A New “CRISPR Pill” Makes Bacteria Destroy Its Own DNA – Futurism
Futurism An innovative study in the University of Wisconsin-Madison could soon put an end to drug-resistant bacteria by using an edible version of CRISPR. This probiotic … |
Endpoints News |
CRISPR Therapeutics, Casebia ink AAV deal with StrideBio; Puma gets an AdComm date; Merrimack names new R&D …
Endpoints News CRISPR Therapeutics $CRSP and Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer AG, have inked a collaboration agreement with StrideBio to develop AAV vectors for in vivo gene delivery applications. StrideBio’s task … Chardan Capital Initiates Coverage on Crispr Therapeutics AG (CRSP)Sports Perspectives Crispr Therapeutics AG (CRSP) Given Consensus Recommendation of “Strong Buy” by AnalystsThe Cerbat Gem Moody’s (MCO) Reaches $114.33 52-Week High, Crispr Therapeutics AG (CRSP) SI Decreased By 6.79%HuronReport Benchmark Monitor –BBNS –Chaffey Breeze all 12 news articles » |